Literature DB >> 22442099

Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study.

Shaw-Ji Chen1, Yu-Lin Chao, Chuan-Yu Chen, Chia-Ming Chang, Erin Chia-Hsuan Wu, Chi-Shin Wu, Hsueh-Han Yeh, Chia-Hsiang Chen, Hui-Ju Tsai.   

Abstract

BACKGROUND: The association between autoimmune diseases and schizophrenia has rarely been systematically investigated. AIMS: To investigate the association between schizophrenia and a variety of autoimmune diseases and to explore possible gender variation in any such association.
METHOD: Taiwan's National Health Insurance Research Database was used to identify 10 811 hospital in-patients with schizophrenia and 108 110 age-matched controls. Univariate and multiple logistic regression analyses were performed, separately, to evaluate the association between autoimmune diseases and schizophrenia. We applied the false discovery rate to correct for multiple testing.
RESULTS: When compared with the control group, the in-patients with schizophrenia had an increased risk of Graves' disease (odds ratio (OR) = 1.32, 95% CI 1.04-1.67), psoriasis (OR = 1.48, 95% CI 1.07-2.04), pernicious anaemia (OR = 1.71, 95% CI 1.04-2.80), celiac disease (OR = 2.43, 95% CI 1.12-5.27) and hypersensitivity vasculitis (OR = 5.00, 95% CI 1.64-15.26), whereas a reverse association with rheumatoid arthritis (OR = 0.52, 95% CI 0.35-0.76) was also observed. Gender-specific variation was found for Sjögren syndrome, hereditary haemolytic anaemia, myasthenia gravis, polymyalgia rheumatica and dermatomyositis.
CONCLUSIONS: Schizophrenia was associated with a greater variety of autoimmune diseases than was anticipated. Further investigation is needed to gain a better understanding of the aetiology of schizophrenia and autoimmune diseases.

Entities:  

Mesh:

Year:  2012        PMID: 22442099     DOI: 10.1192/bjp.bp.111.092098

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  60 in total

Review 1.  Inflammation and the two-hit hypothesis of schizophrenia.

Authors:  Keith A Feigenson; Alex W Kusnecov; Steven M Silverstein
Journal:  Neurosci Biobehav Rev       Date:  2013-11-15       Impact factor: 8.989

Review 2.  Psychiatric manifestations of primary Sjögren's syndrome: a case report and literature review.

Authors:  John K F Wong; Ross Nortley; Thomasin Andrews; David D'Cruz
Journal:  BMJ Case Rep       Date:  2014-05-23

3.  Incidence of autoimmune diseases in patients with scabies: a nationwide population-based study in Taiwan.

Authors:  Jui-Ming Liu; Feng-Hsiang Chiu; Chien-Yu Lin; Fung-Wei Chang; Ren-Jun Hsu
Journal:  Rheumatol Int       Date:  2017-04-18       Impact factor: 2.631

4.  Excess of homozygosity in the major histocompatibility complex in schizophrenia.

Authors:  Semanti Mukherjee; Saurav Guha; Masashi Ikeda; Nakao Iwata; Anil K Malhotra; Itsik Pe'er; Ariel Darvasi; Todd Lencz
Journal:  Hum Mol Genet       Date:  2014-06-18       Impact factor: 6.150

5.  Gluten sensitivity and relationship to psychiatric symptoms in people with schizophrenia.

Authors:  Jessica Jackson; William Eaton; Nicola Cascella; Alessio Fasano; Debby Santora; Kelli Sullivan; Stephanie Feldman; Heather Raley; Robert P McMahon; William T Carpenter; Haley Demyanovich; Deanna L Kelly
Journal:  Schizophr Res       Date:  2014-10-11       Impact factor: 4.939

Review 6.  Neuropsychiatric clinical manifestations in elderly patients treated with hydroxychloroquine: a review article.

Authors:  Annamaria Mascolo; Pasquale Maria Berrino; Pietro Gareri; Alberto Castagna; Annalisa Capuano; Ciro Manzo; Liberato Berrino
Journal:  Inflammopharmacology       Date:  2018-06-09       Impact factor: 4.473

7.  Association between schizophrenia and an autoimmune bullous skin disease-pemphigus: a population-based large-scale study.

Authors:  K Kridin; S Zelber-Sagi; D Comaneshter; A D Cohen
Journal:  Epidemiol Psychiatr Sci       Date:  2017-09-25       Impact factor: 6.892

8.  Non-psychiatric hospitalization length-of-stay for patients with psychotic disorders: A mixed methods study.

Authors:  Guy M Weissinger; J Margo Brooks Carthon; Bridgette M Brawner
Journal:  Gen Hosp Psychiatry       Date:  2020-07-31       Impact factor: 3.238

9.  Activated Phosphorylated STAT1 Levels as a Biologically Relevant Immune Signal in Schizophrenia.

Authors:  Rajiv P Sharma; Cherise Rosen; Jennifer K Melbourne; Benjamin Feiner; Kayla A Chase
Journal:  Neuroimmunomodulation       Date:  2016-11-08       Impact factor: 2.492

Review 10.  Major histocompatibility complex I in brain development and schizophrenia.

Authors:  A Kimberley McAllister
Journal:  Biol Psychiatry       Date:  2013-10-10       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.